Disease-specific quality of life-patient acceptance: racial and gender differences in patients with implantable cardioverter defibrillators

The Journal of Cardiovascular Nursing
Mary H WilsonJanice A Neil

Abstract

Despite its established effectiveness, living with an implantable cardioverter defibrillator (ICD) is associated with ongoing physical and psychosocial distress. Little is known about which factors impact the patients' adjustment to living with the device and whether there are racial or gender differences related to these factors. The purpose of this study was to investigate factors (demographic, clinical, psychosocial, and religiosity) related to patients' ICD acceptance and to examine racial and gender differences in ICD acceptance. A total of 101 ICD patients (mean age, 65 ± 12.8 years, 34% female, 42% African American [AA]) seen in a cardiology clinic between January and August 2010 completed the Florida Patient Acceptance Survey (FPAS), Florida shock anxiety scale, ENRICHD social support instrument, hospital anxiety and depression scale, Hoge Religiosity Scale, and a demographic sheet during their clinic visit. All multiple-item scales demonstrated good internal consistency reliability, with Cronbach α values ranging from .77 to .89. Overall patient acceptance of the ICD was high, with an average FPAS acceptance score of 80.9 on the 0-to-100 point scale. The FPAS subscale scores indicated that the group was very positive a...Continue Reading

References

Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Apr 18, 1998·The American Journal of Psychiatry·H G KoenigB L Peterson
Jan 5, 2002·Mayo Clinic Proceedings·P S MuellerT A Rummans
Feb 8, 2002·Journal of Psychosomatic Research·Ingvar BjellandDag Neckelmann
May 9, 2002·Heart·Samuel F Sears, Jamie B Conti
Aug 31, 2002·Journal of Cardiopulmonary Rehabilitation·Robyn L WallaceJamie B Conti
Apr 20, 2004·Journal of the American College of Cardiology·Henry GreenbergUNKNOWN MADIT-II Investigators
Jul 28, 2004·Archives of Internal Medicine·Harold G KoenigKeith G Meador
Jan 6, 2005·Cancer Nursing·Terry Lynn Gall
Jun 21, 2006·Pacing and Clinical Electrophysiology : PACE·Ahmet Kaya BilgeKamil Adalet
Feb 24, 2007·The Journal of Cardiovascular Nursing·Ann Sossong
Apr 18, 2007·Pacing and Clinical Electrophysiology : PACE·Peter W GroeneveldJudy A Shea
May 16, 2007·The Journal of Nervous and Mental Disease·Harold G Koenig
Jan 10, 2008·Journal of General Internal Medicine·Chunliu ZhanClaudia Steiner
Jun 24, 2009·Dimensions of Critical Care Nursing : DCCN·Erlinda C WheelerRita Lucey
Nov 27, 2010·Heart Failure Clinics·J Michael Bostwick, Christopher L Sola

❮ Previous
Next ❯

Citations

Sep 2, 2015·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Ingela ThylénMisook L Chung
Jun 15, 2017·European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology·Joanna SweetingJodie Ingles
Jun 23, 2018·Pacing and Clinical Electrophysiology : PACE·Vivi S FrydensbergRobin N Kok
Aug 30, 2019·Pacing and Clinical Electrophysiology : PACE·Connor TrippSamuel F Sears
Aug 30, 2019·Pacing and Clinical Electrophysiology : PACE·Youssef Jalloul, Marwan M Refaat
Feb 24, 2021·European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology·Jasprit PannagSandra L Carroll
Jun 7, 2021·Journal of Cardiovascular Electrophysiology·Vivi Skibdal FrydensbergSusanne S Pedersen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.